Curriculum Vitae Lisa Hazard, M.D. License Arizona State License # Education

Transcription

1 Curriculum Vitae Lisa Hazard, M.D. License Arizona State License #42470 Education Dartmouth College Hanover, NH BS, State University of New York at Buffalo Buffalo, NY MD, University of Utah Salt Lake City, UT Internship, Internal Medicine, University of Utah, Huntsman Cancer Hospital Salt Lake City, UT Resident, Radiation Oncology, University of Utah, Huntsman Cancer Hospital Salt Lake City, UT Chief Resident, Radiation Oncology, 2004 Original Publications Tuttle SW, Hazard LJ, Koch CJ, Mitchell, JB, Coleman CN, Biaglow JE. Bioreductive metabolism of SR-4233 by whole cell suspensions under aerobic and hypoxic conditions: role of the pentose cycle and Implications for the mechanism of cytotoxicity observed in air. Int J Radiat Oncol Biol Phys 1994; 29(2): Hazard LJ, Sause WT, and Noyes RD. Combined adjuvant radiation and Interferon-alpha 2b therapy in high-risk melanoma patients: the potential for increased radiation toxicity. Int J Radiat Oncol Biol Phys 2002; 52(3): Hazard LJ, Miercort CM, Gaffney DK, Leavitt D, Stewart JR. Electron arc radiotherapy after breast reconstruction: A case control study. Am J Clin Oncol. 2004; 27(6): Shrieve DS, Hazard LJ, Boucher K, and Jensen R. Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and nerve tolerance. J Neurosurg. 2004; 101 Suppl 3: O Connor J, Sause W, Hazard L, Belnap L, Noyes RD. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma. International Journal of Radiation Oncology, Biology, and Physics. 2005; 63(4): O Connor J, Hazard LJ, Avent JM, Lee RJ, Fischbach J, Gaffney DK. Topoisomerase IIalpha expression correlates with diminished disease-free survival in invasive breast cancer. International Journal of Radiation Oncology, Biology, and Physics. 2006; 65(5): Hazard L, Tward JD, Szabo A, Shrieve DC. Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: results of a study from the Surveillance, Epidemiology, and End Results (SEER) registry data. Cancer. 2007; 110(10): Hazard L, Wang B, Skidmore T, Chern S, Salter B, Jensen R, Shrieve D. Conformity of LINAC-based stereotactic radiosurgery using dynamic conformal arc and multileaf collimator. International Journal of Radiation Oncology, Biology, and Physics. 2008; 73(2):

2 Hazard L, Sklow, B, Pappas L, Boucher K, Sklow B. Local Excision versus Radical Resection in T1-2 Rectal Carcinoma: Results of a Study From the Surveillance, Epidemiology, and End Results (SEER) Registry Data. Gastrointestinal Cancer Research. 2009; 3(3): Eliason M, Bowen G, Bowen A, Hazard L, Samlowski W. Primary treatment of verrucous carcinoma of the penis with fluorouracil, cis-diamino-dichloro-platinum, and radiation therapy. Arch Dermatol. 2009; 145(11):1291. Jensen RL, Jensen PR, Shrieve AF, Hazard L, Shrieve DC. Overall and progression-free survival and visual and endocrine outcomes for patients with parasellar lesions treated with intensity-modulated stereotactic radiosurgery. J Neurooncol. 2010; 98(2): Hazard L, Jones K, Shaaban A, Anker C, Scaife C, Weis J, and Mulvihill S et al. Prospective Phase I Study of Capecitabine and Oxaliplatin Concurrent with Radiation Therapy for the Treatment of Locally Advanced Pancreatic Adenocarcinoma, and Retrospective Comparison to Concurrent 5-Fluorouracil/Radiation and Gemcitabine/Radiation. Gastrointestinal Cancer Research. 2012; 43(2): Anker C, Hymas R, Hazard L, Boucher K, Jensen R, Shrieve D. Stereotactic radiosurgery eligibility and selection bias in the treatment of glioblastoma multiforme. J Neurooncol. 2010; 98(2): Review Articles Hazard LJ, and Sause WT. The treatment of unresectable, locally advanced lung cancer: Radiation therapy perspective with an emphasis on the trials of the Radiation Therapy Oncology Group. Clinical Lung Cancer 2002; 3(3): Hazard L, Jensen R, and Shrieve D. Role of stereotactic radiosurgery in the treatment of brain metastases. Am J Clinic Oncol 2005; 28: Hazard L, O Connor J, and Scaife C. The Role of radiation therapy in gastric cancer. World Journal of Gastroenterology 2006; 12: Hazard L, Yang G, McAlleer MF, Hayman J, Willett C. Principles and techniques of radiation therapy for esophagus and gastroesophageal junction cancers. J Natl Compr Canc Netw. 2009;6(9): Hazard L, Tward JD, Shrieve DC. Adjuvant EBRT improves survival in patients with lymphnode-negative pancreatic cancer. Nat Clin Pract Oncol. 2008;5(8): Ajani, JA, Barthel JS, Hazard L, et al. Esophageal cancer. J Natl Compr Canc Netw. 2008;6(9): Hazard L. The Role of radiation therapy in pancreas cancer. Gastrointest Cancer Res. 2009;3(1): Ajani, JA, Barthel JS, Hazard L, et al. Gastric cancer. J Natl Compr Canc Netw. 2010;8(4): Cooke E and Hazard L. Curative radiation therapy for pancreatic malignancies. Surg Clin North Am. 2010; 90(2): Vonk D and Hazard L. Do all locally advance rectal cancers require radiation? A review of the literature in the modern era. J of Gastrointestinal Oncology. 2010;1(1).

3 Stea B, Hazard LJ, Gonzalez VJ, Hamilton R. The Role of Radiation Therapy in the Control of Locoregional and Metastatic Cancer. J. Surg. Oncol. 2011;103: Book Chapters Hazard LJ and Sause WT Combined Modality Therapy for Unresectable Non-Small Cell Lung Cancer. In: Sculier J.P., Fry, W.A., eds. Malignant Tumors of the Lung. Heidelberg: Springer Press, Hazard LJ and Minsky BD. Esophageal Injury. In: Loeffler J and Shrieve D, eds. Human Radiation Injury. Philadelphia: Lippincott, Williams, and Wilkins, Hazard LJ and Rogers L. Intracranial Ependymoma. In: Mehta M, ed. Principles and Practice of Neuro-Oncology, Meeting Presentations: National Hazard L, Sause W, Noyes RD. The Potential for increased radiation toxicity following combined radiation and interferon-alpha 2b therapy in high-risk melanoma patients: updated results. 85 th Annual American Radium Society; Houston, Texas Hazard L, Avizonis V, Watson G. Unilateral versus bilateral neck irradiation in the treatment of carcinoma metastatic to lymph nodes of unknown primary site. 86 th Annual American Radium Society; Napa Valley, CA Hazard L, Leavitt D, Shrieve D. Conformity and Normal Tissue Sparing of Intensity Modulated Stereotactic Radiotherapy Compared to Dynamic Conformal Arc Stereotactic Radiotherapy. 90 th Annual Meeting of the Radiologic Society of North America; Chicago, IL Hazard L, Tward J, O'Connor J, Shrieve D. Pre and Post-Operative Radiation Therapy Improves Survival in Patients with Pancreatic Adenocarcinoma: Results of a Study From the Surveillance, Epidemiology, and End Results (SEER) Registry Data (oral presentation). 48 th Annual Meeting of the American Society of Therapeutic Radiation Oncology (ASTRO); Philadelphia, PA Hazard L, Sklow B, Shrieve D. Local Excision versus Resection in T1-2 Rectal Carcinoma: Results of a Study From the Surveillance, Epidemiology, and End Results (SEER) Registry Data (oral presentation). 49 th Annual Meeting of the American Society of Therapeutic Radiation Oncology (ASTRO); Los Angeles, CA.2007 Educational Presentations and Teaching Experience 3D Conformal Prostate Cancer. 68 th annual meeting of the Radiation Therapy Society of Utah; Park City, UT, 2001 Advances in Radiation Therapy for the Treatment of Gastrointestinal Malignancies. University of Utah Surgical Grand Rounds, Radiation Therapy for Gastrointestinal Malignancies. University of Utah Gastrointestinal Grand Rounds, 2008.

4 Timing of Radiation Therapy in Gastric Cancer. Didactic lecture at the 8 th Annual Oncology Update: Advances and Controversies; The Canyons, Park City, UT, Cases in the Treatment of Colorectal Cancer. Panel member at the 8 th Annual Oncology Update: Advances and Controversies; The Canyons, Park City, UT, Radiation Therapy for Gastrointestinal Malignancies. Portneuf Medical Center; Pocatello, Idaho, Awards and Honors Awarded Presidential Scholarship, Waterhouse Scholarship, and Richter Scholarship, each in recognition of independent research towards a Senior Honors Thesis, Dartmouth College, Completed a Senior Honors Thesis in the Department of Biochemistry, Dartmouth College, 1995 Commendation from the Dean for Academic Excellence, State University of New York at Buffalo School of Medicine, 1999 Awarded Travel Grant to the Radiation Therapy Oncology Group Meeting in Montreal, Quebec, 2003 Awarded Beckstrand Foundation Resident Scholarship, 2003 Awarded Travel Grant to the International Society of Gastrointestinal Research Mentorship Program for Young Oncologists, 2008 Nominated Educator of the Year by the University of Arizona Radiation Oncology Residents, 2011 Professional Affiliations American Society of Radiation Oncology American College of Radiation Oncology American College of Radiology American Medical Association Professional Committees University of Utah Radioactive Drug Research Committee, University of Utah Radiation Safety Committee, University of Utah Institutional Review Board, National Cancer Care Network Panel Member- Pancreas Cancer, National Cancer Care Network Panel Member- Esophageal and Gastric Cancer, University of Arizona Department of Radiation Oncology Workflow Committee,

5 University of Arizona Department of Radiation Oncology Resident Education Committee Chair, University of Arizona Department of Radiation Oncology Staff Satisfaction Committee, Practice Experience Assistant Professor, University of Utah Department of Radiation Oncology 7/ /2009 Associate Professor, University of Arizona Department of Radiation Oncology 1/2010 3/2012 Medical Director, Center for Neurosciences, Radiation Therapy Center 3/2012 present Current Licensures/Certifications Diplomate American Board of Radiology (Radiation Oncology) 2005 to present